Journal ArticleOPEN ACCESS

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Frontiers in Cardiovascular Medicine (2022) 9
DOI: 10.3389/fcvm.2022.964324
3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

Author supplied keywords

Cite

CITATION STYLE

APA

Chye, A. M., Nordman, I. I. C., & Sverdlov, A. L. (2022). Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.964324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free